Cytokinetics Stock Market Value
| CYTK Stock | USD 47.67 2.19 4.39% |
| Symbol | Cytokinetics |
Cytokinetics Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cytokinetics. If investors know Cytokinetics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cytokinetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.25) | Revenue Per Share 0.03 | Quarterly Revenue Growth 0.225 | Return On Assets (0.30) | Return On Equity (5.72) |
The market value of Cytokinetics is measured differently than its book value, which is the value of Cytokinetics that is recorded on the company's balance sheet. Investors also form their own opinion of Cytokinetics' value that differs from its market value or its book value, called intrinsic value, which is Cytokinetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cytokinetics' market value can be influenced by many factors that don't directly affect Cytokinetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cytokinetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cytokinetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cytokinetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cytokinetics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Cytokinetics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Cytokinetics.
| 10/23/2024 |
| 11/22/2024 |
If you would invest 0.00 in Cytokinetics on October 23, 2024 and sell it all today you would earn a total of 0.00 from holding Cytokinetics or generate 0.0% return on investment in Cytokinetics over 30 days. Cytokinetics is related to or competes with ZyVersa Therapeutics, Sonnet Biotherapeutics, Zura Bio, Phio Pharmaceuticals, Transcode Therapeutics, and Quoin Pharmaceuticals. Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializ... More
Cytokinetics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Cytokinetics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Cytokinetics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.11) | |||
| Maximum Drawdown | 14.08 | |||
| Value At Risk | (3.46) | |||
| Potential Upside | 3.42 |
Cytokinetics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Cytokinetics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Cytokinetics' standard deviation. In reality, there are many statistical measures that can use Cytokinetics historical prices to predict the future Cytokinetics' volatility.| Risk Adjusted Performance | (0.05) | |||
| Jensen Alpha | (0.34) | |||
| Total Risk Alpha | (0.45) | |||
| Treynor Ratio | (0.1) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Cytokinetics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Cytokinetics Backtested Returns
Cytokinetics secures Sharpe Ratio (or Efficiency) of -0.1, which signifies that the company had a -0.1% return per unit of risk over the last 3 months. Cytokinetics exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Cytokinetics' Standard Deviation of 2.41, mean deviation of 1.79, and Risk Adjusted Performance of (0.05) to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 1.84, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Cytokinetics will likely underperform. At this point, Cytokinetics has a negative expected return of -0.25%. Please make sure to confirm Cytokinetics' total risk alpha, kurtosis, as well as the relationship between the Kurtosis and day typical price , to decide if Cytokinetics performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.4 |
Poor reverse predictability
Cytokinetics has poor reverse predictability. Overlapping area represents the amount of predictability between Cytokinetics time series from 23rd of October 2024 to 7th of November 2024 and 7th of November 2024 to 22nd of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Cytokinetics price movement. The serial correlation of -0.4 indicates that just about 40.0% of current Cytokinetics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.4 | |
| Spearman Rank Test | 0.18 | |
| Residual Average | 0.0 | |
| Price Variance | 12.05 |
Cytokinetics lagged returns against current returns
Autocorrelation, which is Cytokinetics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Cytokinetics' stock expected returns. We can calculate the autocorrelation of Cytokinetics returns to help us make a trade decision. For example, suppose you find that Cytokinetics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Cytokinetics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Cytokinetics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Cytokinetics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Cytokinetics stock over time.
Current vs Lagged Prices |
| Timeline |
Cytokinetics Lagged Returns
When evaluating Cytokinetics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Cytokinetics stock have on its future price. Cytokinetics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Cytokinetics autocorrelation shows the relationship between Cytokinetics stock current value and its past values and can show if there is a momentum factor associated with investing in Cytokinetics.
Regressed Prices |
| Timeline |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Cytokinetics Correlation, Cytokinetics Volatility and Cytokinetics Alpha and Beta module to complement your research on Cytokinetics. For more information on how to buy Cytokinetics Stock please use our How to buy in Cytokinetics Stock guide.You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Cytokinetics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.